DUAL-FUNCTION BONE-TARGETING PEPTIDE LINKED PRO-DRUGS FOR THE TREATMENT OF OSTEOPOROSIS

被引:0
作者
Xie, H. [1 ]
Chen, G. [1 ]
Young, R. N. [1 ]
机构
[1] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
关键词
Pro-drug; esterase; cathepsin K; bisphosphonate; osteoporosis;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
O44
引用
收藏
页码:S65 / S66
页数:2
相关论文
共 12 条
  • [1] Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis
    Arns, Steve
    Gibe, Romelo
    Moreau, Anne
    Morshed, M. Monzur
    Young, Robert N.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (06) : 2131 - 2140
  • [2] Design, Synthesis, and Pharmacokinetics of a Bone-Targeting Dual Action Prodrug for the Treatment of Osteoporosis
    Xie, Haibo
    Chen, Gang
    Young, Robert N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (16) : 7012 - 7028
  • [3] Bone-Targeting Peptide and RNF146 Modified Apoptotic Extracellular Vesicles Alleviate Osteoporosis
    Gui, Linyuan
    Ye, Qingyuan
    Yu, Lu
    Dou, Geng
    Zhou, Yang
    Liu, Yang
    Zhang, Yanqi
    Yang, Xiaoshan
    Jin, Fang
    Liu, Shiyu
    Jin, Yan
    Ren, Lili
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 471 - 488
  • [4] Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats
    Yang Yang
    Ali Aghazadeh-Habashi
    Arash Panahifar
    Yuchin Wu
    Krishna H. Bhandari
    Michael R. Doschak
    Drug Delivery and Translational Research, 2017, 7 : 482 - 496
  • [5] Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats
    Yang, Yang
    Aghazadeh-Habashi, Ali
    Panahifar, Arash
    Wu, Yuchin
    Bhandari, Krishna H.
    Doschak, Michael R.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2017, 7 (04) : 482 - 496
  • [6] Design, Synthesis, Pharmacokinetics, and Biodistribution of a Series of Bone-Targeting EP4 Receptor Agonist Prodrugs for Treatment of Osteoporosis and Other Bone Conditions
    Thevenin, Marion
    Chen, Gang
    Kantham, Srinivas
    Sun, Chunxiang
    Glogauer, Michael
    Young, Robert N.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (02) : 908 - 925
  • [7] A bone-targeting delivery platform based on mesoporous silica loaded with piR7472 for the treatment of osteoporosis
    Long, Yubin
    Ma, Yuan
    Yang, Houzhi
    Wang, Xiangbin
    Fan, Jigeng
    Li, Yong
    Tao, Bo
    Sun, Tianwei
    ARABIAN JOURNAL OF CHEMISTRY, 2024, 17 (12)
  • [8] Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis
    Sun, Xiaoduan
    Wei, Jun
    Lyu, Jiayao
    Bian, Tierong
    Liu, Zhongbing
    Huang, Juan
    Pi, Fengjuan
    Li, Chunhong
    Zhong, Zhirong
    JOURNAL OF NANOBIOTECHNOLOGY, 2019, 17 (1)
  • [9] Poly aspartic acid peptide-linked PLGA based nanoscale particles: Potential for bone-targeting drug delivery applications
    Jiang, Tao
    Yu, Xiaohua
    Carbone, Erica J.
    Nelson, Clarke
    Kan, Ho Man
    Lo, Kevin W. -H.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 475 (1-2) : 547 - 557
  • [10] Synthetic nanoparticles functionalized with cell membrane-mimicking, bone-targeting, and ROS-controlled release agents for osteoporosis treatment
    Zhang, Weijun
    Zhang, Ye
    Hao, Zhengan
    Yao, Pengjie
    Bai, Jinwu
    Chen, Hongyu
    Wu, Xiaoyong
    Zhong, Yuliang
    Xue, Deting
    JOURNAL OF CONTROLLED RELEASE, 2025, 378 : 306 - 319